AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 66 filers reported holding AQUESTIVE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.09 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,600 | -7.3% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $33,000 | +15.8% | 20,000 | -20.0% | 0.00% | 0.0% |
| Q1 2023 | $28,500 | -1.3% | 25,000 | -21.9% | 0.00% | 0.0% |
| Q4 2022 | $28,867 | -9.8% | 32,000 | +18.5% | 0.00% | -33.3% |
| Q3 2022 | $32,000 | +88.2% | 27,000 | 0.0% | 0.00% | +200.0% |
| Q2 2022 | $17,000 | -66.7% | 27,000 | +38.5% | 0.00% | -66.7% |
| Q1 2022 | $51,000 | -32.9% | 19,500 | 0.0% | 0.00% | -40.0% |
| Q4 2021 | $76,000 | +2.7% | 19,500 | +14.7% | 0.01% | 0.0% |
| Q3 2021 | $74,000 | +10.4% | 17,000 | 0.0% | 0.01% | +25.0% |
| Q2 2021 | $67,000 | -1.5% | 17,000 | +30.8% | 0.00% | -20.0% |
| Q1 2021 | $68,000 | -10.5% | 13,000 | -8.5% | 0.01% | 0.0% |
| Q4 2020 | $76,000 | – | 14,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 11,503,294 | $66,949,000 | 80.13% |
| Opaleye Management Inc. | 738,500 | $4,298,000 | 0.84% |
| Wildcat Capital Management, LLC | 455,358 | $2,650,000 | 0.76% |
| One68 Global Capital, LLC | 34,543 | $201,000 | 0.43% |
| Eversept Partners, LP | 350,000 | $2,037,000 | 0.36% |
| Worth Venture Partners, LLC | 94,500 | $550,000 | 0.27% |
| Leap Investments LP | 71,809 | $418,000 | 0.20% |
| Bracebridge Capital, LLC | 428,571 | $2,000,000 | 0.16% |
| Granite Point Capital Management, L.P. | 160,099 | $932,000 | 0.15% |
| True North Advisors, LLC | 32,295 | $187,000 | 0.05% |